(Q40397170)

English

Evidence for encapsidation of prokaryotic sequences during recombinant adeno-associated virus production and their in vivo persistence after vector delivery.

scientific article published on October 2005

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16023415%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Evidence for encapsidation of prokaryotic sequences during recombinant adeno-associated virus production and their in vivo persistence after vector delivery (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16023415%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

viral persistence

0 references

vector-borne disease

0 references

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16023415%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

author name string

Gilliane Chadeuf

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16023415%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Carine Ciron

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16023415%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Philippe Moullier

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16023415%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

publication date

1 October 2005

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16023415%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Molecular Therapy

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16023415%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16023415%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16023415%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

744-753

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16023415%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Novel tools for production and purification of recombinant adenoassociated virus vectors

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.06.003

7 January 2021

Cell lines for the production of recombinant adeno-associated virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.06.003

7 January 2021

A novel gene expression control system and its use in stable, high-titer 293 cell-based adeno-associated virus packaging cell lines

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.06.003

7 January 2021

Identification of a replication-defective herpes simplex virus for recombinant adeno-associated virus type 2 (rAAV2) particle assembly using stable producer cell lines

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.06.003

7 January 2021

High-titer recombinant adeno-associated virus production utilizing a recombinant herpes simplex virus type I vector expressing AAV-2 Rep and Cap.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.06.003

7 January 2021

Factors influencing recombinant adeno-associated virus production

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.06.003

7 January 2021

Evidence for packaging of rep-cap sequences into adeno-associated virus (AAV) type 2 capsids in the absence of inverted terminal repeats: a model for generation of rep-positive AAV particles

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.06.003

7 January 2021

Novel cis-acting replication element in the adeno-associated virus type 2 genome is involved in amplification of integrated rep-cap sequences.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.06.003

7 January 2021

Chromosomal effects of adeno-associated virus vector integration

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.06.003

7 January 2021

In vitro excision of adeno-associated virus DNA from recombinant plasmids: isolation of an enzyme fraction from HeLa cells that cleaves DNA at poly(G) sequences

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.06.003

7 January 2021

Cloning of adeno-associated virus into pBR322: rescue of intact virus from the recombinant plasmid in human cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.06.003

7 January 2021

In vitro rescue of an integrated hybrid adeno-associated virus/simian virus 40 genome

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.06.003

7 January 2021

Recombinant adeno-associated viral vector production using stable packaging and producer cell lines

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.06.003

7 January 2021

Characterization of adenovirus-induced inverted terminal repeat-independent amplification of integrated adeno-associated virus rep-cap sequences

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.06.003

7 January 2021

Optimization of recombinant adeno-associated virus production using an herpes simplex virus amplicon system

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.06.003

7 January 2021

Novel strategy for generation and titration of recombinant adeno-associated virus vectors.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.06.003

7 January 2021

Insect cells as a factory to produce adeno-associated virus type 2 vectors

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.06.003

7 January 2021

Optimal design of a single recombinant adeno-associated virus derived from serotypes 1 and 2 to achieve more tightly regulated transgene expression from nonhuman primate muscle

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.06.003

7 January 2021

Extrachromosomal recombinant adeno-associated virus vector genomes are primarily responsible for stable liver transduction in vivo

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.06.003

7 January 2021

Genetic fate of recombinant adeno-associated virus vector genomes in muscle

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.06.003

7 January 2021

From virus evolution to vector revolution: use of naturally occurring serotypes of adeno-associated virus (AAV) as novel vectors for human gene therapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.06.003

7 January 2021

Cloning of infectious adeno-associated virus genomes in bacterial plasmids

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.06.003

7 January 2021

Circular intermediates of recombinant adeno-associated virus have defined structural characteristics responsible for long-term episomal persistence in muscle tissue

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.06.003

7 January 2021

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40397170&oldid=1568442741"